KIROPRAKTISK KLINIK JAKOB SANVIG ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  21.5% 18.4% 18.4% 8.1% 11.1%  
Credit score (0-100)  4 7 7 29 22  
Credit rating  B B B BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  -214 0.0 0.0 -140 -237  
EBITDA  -820 0.0 0.0 -728 -864  
EBIT  -820 0.0 0.0 -800 -936  
Pre-tax profit (PTP)  269.0 0.0 0.0 396.0 114.6  
Net earnings  269.0 0.0 0.0 309.0 89.3  
Pre-tax profit without non-rec. items  -820 0.0 0.0 396 115  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 327 255  
Shareholders equity total  577 0.0 0.0 652 619  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  822 0.0 0.0 958 914  

Net Debt  0.0 0.0 0.0 -264 -401  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -214 0.0 0.0 -140 -237  
Gross profit growth  0.0% 0.0% 0.0% 0.0% -69.0%  
Employees  1 0 0 1 1  
Employee growth %  0.0% -100.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  822 0 0 958 914  
Balance sheet change%  0.0% -100.0% 0.0% 0.0% -4.6%  
Added value  -820.0 0.0 0.0 -800.0 -864.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -184 0 0 255 -143  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -4.0 0.0 0.0 -1.0 -2.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  383.2% 0.0% 0.0% 571.4% 395.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -99.8% 0.0% 0.0% 41.6% 13.0%  
ROI %  -117.2% 0.0% 0.0% 59.3% 18.5%  
ROE %  46.6% 0.0% 0.0% 47.4% 14.0%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  100.0% 0.0% 0.0% 68.1% 67.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% 36.3% 46.3%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.0 0.0 0.0 1.2 1.8  
Current Ratio  0.0 0.0 0.0 1.2 1.8  
Cash and cash equivalent  0.0 0.0 0.0 264.0 400.5  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 56.0 213.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  -820 0 0 -800 -864  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -820 0 0 -728 -864  
EBIT / employee  -820 0 0 -800 -936  
Net earnings / employee  269 0 0 309 89